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Acute hepatic failure during pregnancy is a life-threatening situation for the mother and fetus and might need a super-urgent liver
transplantation. Many pregnancies with positive outcomes are reported after a previous liver transplantation before the pregnancy,
but only a few of them are mentioned with transplantation during pregnancy. In these few cases, fetal outcome is mostly adverse.
Experience with liver failure during pregnancy and its management is still deficient and needs to be approved. For sure, patients
need to be treated in highly qualified centers in a multidisciplinary approach. We present a case of successful super-urgent liver
transplantation during the second trimester of pregnancy after acute hepatic failure due to an acute hepatitis B infection with
positive maternal and fetal outcome. Liver transplantation during pregnancy due to an acute liver failure can be a life-saving
procedure for the mother and fetus. An early initiated maternal therapy with antiviral drugs and immunoglobulins seems to be safe
and able to prevent fetal infection and immunosuppressive therapy after transplantation seems to be well tolerated. Nevertheless,
fetal outcome differs widely and long-term outcome is deficiently known.
1. Introduction
Acute hepatic failure is always a life-threatening situation.
Sometimes, the only solution solving the problem is a
super-urgent liver transplantation. An ongoing pregnancy
aggravates such a situation, as two people’s lives are involved,
the one of the mother and the fetus. Many pregnancies with
positive outcomes are reported after liver transplantation
before getting pregnant, but only a few cases are mentioned
with transplantation during pregnancy [1–21].
2. Case Presentation
A 30-year-old primigravida at 22 0/7 gestational weeks
(GW) was admitted to our hospital in suspicion of an
acute hepatitis B infection. She had presented herself in
another hospital with slight nausea and vomiting, pruritus,
slight jaundice, dark urine, a fairly affected overall condition,
and a positive blood test for acute hepatitis B infection.
The source of the infection remained unknown. Her blood
pressure, heart rate, and oxygen saturation were normal,
as well as her urine analysis besides an elevated bilirubin
level. She showed no signs of edema or hyperreflexia but
slight jaundice and icteric sclera. Her cardiac and pulmonary
status was unaffected, and her temperature was elevated
to 38.8∘C. Her laboratory work-up showed a progressive
hepatic failure (Table 1). HELLP syndrome, intoxication with
acetaminophen, Wilson’s disease, hepatic neoplasia, acute
fatty liver of pregnancy, autoimmune hepatitis, and alpha-1-
antitrypsin deficiency as other potential etiologies of acute
liver failurewere excluded by laboratory testing.The infection
screening revealed an acute hepatitis B infection with a viral
load of 170.000.000 IU/mL. Other infections as hepatitis A,
hepatitis C, HIV, cytomegalovirus (CMV), epstein barr virus,
herpes simplex virus, varicella zoster virus, syphilis, toxoplas-
mosis, and parvovirus B19 could be excluded. Her personal
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Table 1: Maternal laboratory values.
Day of admission,
22 0/7 GW
Day of transplantation,
22 3/7 GW
Two days after
transplantation,
22 5/7 GW
Discharge of hospital
(110 days after
transplantation)
Hb in g/L (117–153) 111 83 64 133
Tc in G/L (143–400) 173 194 137 249
INR (<1.2) 1.6 4.6 1.2 1.1
Factor 5 in % (50–150) 27 15 79
Bilirubin in mcM/L (<21) 129 184 37 7
Ammoniac in mcM/L (9–30) 17 49 14
AST in U/L (<35) 4030 1749 347 20
ALT in U/L (10–35) 2775 2272 824 12
GGT in U/L (5–36) 19 17
HBV-DNA IU/mL (0) 117 × 106 110 × 106 6.2 × 106 <20
HBs-Ag in U/mL (<0.05) pos 2748.68 0
Anti-HBs U/L (<10) neg 17 787
HBe-Ag (neg) pos neg
Anti-HBe (neg) pos pos
Anti-HBc-IgM (neg) pos pos
Table 2: Causes of acute hepatic failure during pregnancy.
Causes of hepatic failure Pregnancyrelated
Nonpregnancy
related Testing
HELLP syndrome x Thrombocytes, liver enzymes, hemolysis parameters(LDH, haptoglobin)
Acute fatty liver of pregnancy x Long-chain fatty acids (LCHAD), acylcarnitine
Infections x Serological blood testing
Intoxications (drugs, medication) x Urine/blood testing (qualitative/quantitative drugproof)
Metabolic disorders (e.g., M. Wilson) x Special markers (e.g., ceruloplasmin,alpha-1-antitrypsin), biopsy
Tumors x Imaging, biopsy, tumor markers (e.g., AFP)
Autoimmune disorders x Autoantibodies, biopsy
medical history showed only an infection with chlamydia
trachomatis in early pregnancy, which had been treated
with azithromycin. Her family history revealed no cases of
known hepatitis B infections. The fetus was sonographically
unaffected and well developed according to her gestational
age at admission. A multidisciplinary team of hepatologists,
surgeons, and obstetricians took care of the patient. An
antiviral therapy with tenofovir, 245mg orally once a day,
was initiated immediately. But the patient, who dearly wanted
to keep the pregnancy, had to be added to the super-urgent
liver transplantation list two days after admission according
to Clichy criteria because of rapid progression of hepatic
failure and encephalopathy (lab MELD 33) (Table 1). After
graft allocation and within 24 hours, an orthotopic liver
transplantation with cava preserving technique (piggy back)
and intermittent portocaval shunt was performed to avoid
any cava clamping during transplantation. The operation
was uneventful (six-hour surgery, transfusion of 2 U red
blood cells, and low pressors). Intraoperatively, an additional
treatment with hepatitis B immunoglobulin was started
and continued for 10 days in a dose of 10.000 IU per day
intravenously. Thereafter, it was continued to maintain the
anti-HBs titer >100 IU/mL. Postoperatively, treatment with
tenofovir was continued until 28 6/7 GW. Afterwards, it
was changed to lamivudine 100mg p.o. daily because of
an increase of liver enzymes. Immunosuppression consisted
of corticosteroids and tacrolimus. The corticosteroids were
applied intravenously for the first five days postoperatively in
declining doses of methylprednisolone from 250 to 40mg,
followed by decreasing doses of prednisolone orally from
20mg to 5mg until delivery. Tacrolimus was applied orally
in doses between 5mg and 12mg with the goal to achieve a
blood level of six to eight ng/mL. On the first postoperative
day, the patient could be extubated without any problems
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and recovered quickly. The histopathological examination of
the explanted liver confirmed subtotal necrosis of the liver
with extensive cholestasis and predominantly lymphocytic
hepatitis. Subsequentmaternal sonographic controls and lab-
oratory testing showed normal liver function and perfusion.
Subsequent biopsies of the transplanted liver due to elevated
liver enzymes at day six after transplantation, could exclude
a graft rejection. Eleven days after liver transplantation fetal
sonography revealed hepatomegaly and intracranial ven-
triculomegaly (Figure 1(a)). Additionally, small hematomas
in the plexus choroideus on both sides and a subdural bleed-
ing in the posterior cranial fossa were detected (Figure 1(b)).
Therefore, an additional MRI of the fetus was arranged five
days later and confirmed a mild ventriculomegaly on both
sides. However, the hepatomegaly could not be confirmed.
Repeated sonographic and MRI examinations showed total
restitution of the former findings during the course of
pregnancy (Figure 1(c)). Because the patient suffered from
preterm uterine contractions, tocolytic agents in form of
nifedipine 60mg orally twice a day in an off-label-use were
applied and had to be changed to intravenous admission of
hexoprenaline at 28 4/7GWbecause of ongoing contractions.
The patient developed gestational diabetes, which could be
well controlled by diet. With 34GW a CMV reactivation
was detected and treated with CMV immunoglobulins intra-
venously. An elective cesarean delivery was performed at 36
0/7 GW due to increasing discomfort and strong demand of
the patient. A healthymale newborn of 2700 g (42. percentile)
was deliveredwith anAPGAR score of 6-4-7 and an umbilical
artery pH of 7.39. The child was transferred to our neonatal
intensive care unit for better surveillance. A fetal hepatitis B
and CMV infection could be excluded by serological testing
of the fetal blood and urine. The mother’s and child’s course
were uneventful and they were dismissed eight and 20 days
after the cesarean section, respectively.
3. Discussion
Acute liver failure during pregnancy is a rare but potentially
life-threatening disease. Causes of acute liver failure can
be pre-existing, pregnancy related, or can occur during
pregnancy without being directly related to it (Table 2).
Depending on the age of gestation and the viability of the
fetus, termination of pregnancy before or during transplan-
tation or maintaining pregnancy has to be discussed with
the patient. A multidisciplinary approach is mandatory and
the treatment of patients with acute liver failure during preg-
nancy should take place in a highly qualified and specialized
center.
Besides our case, 18 other cases of liver transplantation
during pregnancy were described (Table 3). The reasons
for transplantation were acute liver failure due to different
etiologies (Table 3). All liver transplantation procedures were
performed with piggy back technique. According to current
guidelines, immunosuppressive treatment mostly consists of
a combination of a calcineurin inhibitor (e.g., tacrolimus)
and corticosteroids [19, 21, 22], as it was in our patient. She
tolerated the medication without any problems.
(a) Ventriculomegaly on both sides
(b) Subdural bleeding in the posterior cranial fossa
(c) Normal seized ventricles
Figure 1: Sonographic images.
Described side effects during pregnancy after liver trans-
plantation, when transplantation was performed before the
begin of a pregnancy, are hypertension (26–46%), preeclamp-
sia (9–26%), cholestasis (3–27%), graft rejection (7–12%), dia-
betes (5–13%), osteoporosis, neurotoxicity, impaired mater-
nal renal function, maternal infections (9–27%), cesarean
delivery (23–47%), preterm delivery (31–39%), fetal growth
restriction (17–34%), indistinct fetal malformations (0–3%),
and complications of the newborn (17–33%) with a perinatal
mortality of 0–4% [19–24].
Side effects after transplantation during the ongoing preg-
nancy in the 18 cases differed little, with cholestasis (22%),
graft rejections (25%), impaired maternal renal function
(6%), maternal infections (13%), cesarean delivery (25%),
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Table 3: Eighteen other cases of liver transplantation during pregnancy in the literature.
Publication GW attransplantation Etiology Maternal outcome Delivery mode, GW Fetal outcome
Anders et al. [1] 20 Unknown Survived Curettage, 20 GW Intrauterine fetal death(IUFD)
Catnach et al. [2] 20 Autoimmune Survived, PPROM Spontaneous, 28GW Survived
Eguchi et al. [3] 15 Unknown Survived, cytomegalyinfection Curettage, 20 GW Abortion
Fair et al. [4] 22 Hepatitis B Survived, Retransplantation Cesarean, 30 GW Survived, intrauterinegrowth restriction (IUGR)
Finlay et al. [5] 17.5 Unknown Survived Spontaneous, 28.5GW IUFD
Hamilton et al. [6] 21 Hepatitis B Survived Spontaneous, 22GW IUFD
Jarufe et al. [7] 22 Unknown
Survived, reoperation
(biliary stenosis), mild graft
reaction, preterm
contractions
Spontaneous, 27
GW Survived, no compromises
Laifer et al. [8] 26 Hepatitis B Survived, Retransplantation Cesarean, 28 GW Neonatal death
Laifer et al. [9] 23 Autoimmune
Survived; infection, renal
insufficiency, anemia,
thrombozytopenia,
hypotension graft reaction
Spontaneous, 23
GW IUFD
Lo et al. [10] 26 Unknown Survived Spontaneous, 26GW IUFD 26
Kato et al. [11] 13 Unknown
Survived, reoperation
(insufficient biliary
anastomosis)
Miscarriage, 13 GW Miscarriage
Moreno et al. [12] 27 Unknown Survived Cesarean, term Survived
Morris et al. [13] 27 Drug (PTU) Survived Spontaneous, 27GW Neonatal death
Sequeira et al. [14] 18 Drug (PTU) Survived Cesarean, 37 GW
IUGR, microcephaly,
oligohydramnion,
ventriculomegaly,
ischemic enzephalopathy,
seizures
Jankovic et al. [15] 13.5 Autoimmune Survived Spontaneous, 36GW No compromises
Maddukuri et al. [16] 11 Unknown Survived Spontaneous, 30GW
Normally developed at
age of 4 years
Simsek et al. [17] 18 Hepatitis A Survived Induced abortion 18GW
Abortion, growth
restriction,
oligohydramnion
Thornton and Minns
[18] 20 5/7 Drug Survived Induced abortion
Abortion, hydrops,
bilateral ventriculomegaly
preterm delivery (44%), fetal growth restriction (22%), com-
plications of the newborn (19%), and perinatal mortality
(50%) [1–18]. Concerning our case,maternal complications in
form of a steroid induced gestational diabetes, a reactivation
of CMV-infection due to the immunosuppressivemedication
and preterm contractions, well controlled by tocolysis, took
place. No serious complications were found. Concerning
the fetus, intermittent intracranial ventriculomegaly and
intracranial bleeding with a total restitution in the further
course of pregnancy were documented. The reason for these
intermittent changes was unclear. By treating the mother
with antiviral drugs and immunoglobulins against hepatitis B
and CMV, an infection of the newborn could be successfully
prevented. In the end, a normally sized and developed
newborn was delivered almost at term. Its development a
year after the birth its absolutely normal and uncomplicated,
but the neurological long-term outcome is still unknown. In
comparison, fetal outcome in the other 18 cases described in
the literature showed a wide range from abortion to delivery
of a normal fetus (Table 3).
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We conclude that super-urgent liver transplantation due
to an acute hepatitis B infection during pregnancy can
be a life-saving procedure for the mother and fetus. An
early initiated maternal therapy with antiviral drugs and
immunoglobulins seems to be safe and able to prevent fetal
infection. Although perinatal mortality is high, on one hand,
because of intrauterine fetal death in the course and on the
other hand, because of induced abortion for fear of fetal
complications, maintaining the pregnancy should always be
discussed with the mother. As especially our case and few
others show, maintaining the pregnancy is an option in case
of acute liver failure with the necessity of transplantation
andpositive outcome is possible.Nevertheless, fetal outcomes
after transplantation during pregnancy are diverse and long-
term outcomes are deficiently known. But as our case shows,
there are good chances of positive outcome for affected
patients and their offspring as long as they are treated
in highly specialized centers with intense treatment and
observation.
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